Summary

Global Mevalonolactone market size in terms of revenue is projected to reach 15.95 million USD by 2031 from 8.55 million USD in 2024, with a CAGR 7.10% during 2025-2031. North America market for Mevalonolactone is estimated to increase from 2.15 million USD in 2024 to reach 3.65 million USD by 2031, at a CAGR of 4.46% during the forecast period of 2025 through 2031. Europe market for Mevalonolactone is estimated to increase from 2.20 million USD in 2024 to reach 3.71 million USD by 2031, at a CAGR of 5.18% during the forecast period of 2025 through 2031. Asia-Pacific market for Mevalonolactone is estimated to increase from 3.95 million USD in 2024 to reach 8.12 million USD by 2031, at a CAGR of 9.46% during the forecast period of 2025 through 2031. The major global manufacturers of Mevalonolactone include Adeka, Hubei Guangao Biotechnology, Hubei Wande Chemical, etc. In 2024, the world's top three vendors accounted for approximately 62.92% of the revenue. Report Scope This report aims to provide a comprehensive presentation of the global market for Mevalonolactone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mevalonolactone. The Mevalonolactone market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mevalonolactone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mevalonolactone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. Market Segmentation This report covers the Mevalonolactone segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2020-2024, 2025-2031), considering 2024 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market. By Company Adeka Hubei Guangao Biotechnology Hubei Wande Chemical Segment by Type ≥98% <98% Segment by Application Cosmetics Others By Region North America U.S. Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Europe Germany France U.K. Italy Russia Latin America Mexico Brazil Middle East & Africa Saudi Arabia U.A.E Egypt South Africa Chapter Outline Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa. Chapter Two: Detailed analysis of Mevalonolactone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc. Chapter Three: Sales, revenue of Mevalonolactone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world. Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa. Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country. Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter Twelve: Analysis of sales channel, distributors and customers. Chapter Thirteen: Research Findings and Conclusion.

ページTOPに戻る

Table of Contents

1 Mevalonolactone Market Overview 1 1.1 Mevalonolactone Product Overview 1 1.2 Mevalonolactone Market by Type 3 1.2.1 ≥98% 3 1.2.2 <98% 4 1.3 Global Mevalonolactone Market Size by Type 5 1.3.1 Global Mevalonolactone Market Size Overview by Type (2020-2031) 6 1.3.2 Global Mevalonolactone Historic Market Size Review by Type (2020-2025) 7 1.3.3 Global Mevalonolactone Forecasted Market Size by Type (2026-2031) 9 1.4 Key Regions Market Size by Type 10 1.4.1 North America Mevalonolactone Sales Breakdown by Type (2020-2025) 10 1.4.2 Europe Mevalonolactone Sales Breakdown by Type (2020-2025) 12 1.4.3 Asia-Pacific Mevalonolactone Sales Breakdown by Type (2020-2025) 14 1.4.4 Latin America Mevalonolactone Sales Breakdown by Type (2020-2025) 16 1.4.5 Middle East and Africa Mevalonolactone Sales Breakdown by Type (2020-2025) 18 2 Mevalonolactone Market Competition by Company 21 2.1 Global Top Players by Mevalonolactone Sales (2020-2025) 21 2.2 Global Top Players by Mevalonolactone Revenue (2020-2025) 22 2.3 Global Top Players by Mevalonolactone Price (2020-2025) 23 2.4 Global Top Manufacturers Mevalonolactone Manufacturing Base Distribution and Headquarters 23 2.5 Mevalonolactone Market Competitive Situation and Trends 24 2.5.1 Mevalonolactone Market Concentration Rate (2020-2025) 24 2.5.2 Global 3 Largest Manufacturers by Mevalonolactone Revenue in 2024 25 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mevalonolactone as of 2024) 25 2.7 Date of Key Manufacturers Enter into Mevalonolactone Market 26 2.8 Key Manufacturers Mevalonolactone Product Offered 27 3 Mevalonolactone Status and Outlook by Region 28 3.1 Global Mevalonolactone Market Size and CAGR by Region: 2020 VS 2024 VS 2031 28 3.2 Global Mevalonolactone Historic Market Size by Region 28 3.2.1 Global Mevalonolactone Sales in Volume by Region (2020-2025) 28 3.2.2 Global Mevalonolactone Sales in Value by Region (2020-2025) 29 3.2.3 Global Mevalonolactone Sales (Volume & Value), Price and Gross Margin (2020-2025) 30 3.3 Global Mevalonolactone Forecasted Market Size by Region 30 3.3.1 Global Mevalonolactone Sales in Volume by Region (2026-2031) 30 3.3.2 Global Mevalonolactone Sales in Value by Region (2026-2031) 31 3.3.3 Global Mevalonolactone Sales (Volume & Value), Price and Gross Margin (2026-2031) 32 4 Mevalonolactone by Application 33 4.1 Mevalonolactone Market by Application 33 4.1.1 Cosmetics 33 4.1.2 Others 34 4.2 Global Mevalonolactone Market Size by Application 35 4.2.1 Global Mevalonolactone Market Size Overview by Application (2020-2031) 36 4.2.2 Global Mevalonolactone Historic Market Size Review by Application (2020-2025) 37 4.2.3 Global Mevalonolactone Forecasted Market Size by Application (2026-2031) 39 4.3 Key Regions Market Size by Application 40 4.3.1 North America Mevalonolactone Sales Breakdown by Application (2020-2025) 40 4.3.2 Europe Mevalonolactone Sales Breakdown by Application (2020-2025) 42 4.3.3 Asia-Pacific Mevalonolactone Sales Breakdown by Application (2020-2025) 44 4.3.4 Latin America Mevalonolactone Sales Breakdown by Application (2020-2025) 46 4.3.5 Middle East and Africa Mevalonolactone Sales Breakdown by Application (2020-2025) 48 5 North America Mevalonolactone by Country 51 5.1 North America Mevalonolactone Historic Market Size by Country 51 5.1.1 North America Mevalonolactone Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031 51 5.1.2 North America Mevalonolactone Sales in Volume by Country (2020-2025) 51 5.1.3 North America Mevalonolactone Sales in Value by Country (2020-2025) 52 5.2 North America Mevalonolactone Forecasted Market Size by Country 52 5.2.1 North America Mevalonolactone Sales in Volume by Country (2026-2031) 52 5.2.2 North America Mevalonolactone Sales in Value by Country (2026-2031) 53 6 Europe Mevalonolactone by Country 54 6.1 Europe Mevalonolactone Historic Market Size by Country 54 6.1.1 Europe Mevalonolactone Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031 54 6.1.2 Europe Mevalonolactone Sales in Volume by Country (2020-2025) 54 6.1.3 Europe Mevalonolactone Sales in Value by Country (2020-2025) 55 6.2 Europe Mevalonolactone Forecasted Market Size by Country 56 6.2.1 Europe Mevalonolactone Sales in Volume by Country (2026-2031) 56 6.2.2 Europe Mevalonolactone Sales in Value by Country (2026-2031) 57 7 Asia-Pacific Mevalonolactone by Region 58 7.1 Asia-Pacific Mevalonolactone Historic Market Size by Region 58 7.1.1 Asia-Pacific Mevalonolactone Market Size Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 58 7.1.2 Asia-Pacific Mevalonolactone Sales in Volume by Region (2020-2025) 58 7.1.3 Asia-Pacific Mevalonolactone Sales in Value by Region (2020-2025) 59 7.2 Asia-Pacific Mevalonolactone Forecasted Market Size by Region 60 7.2.1 Asia-Pacific Mevalonolactone Sales in Volume by Region (2026-2031) 60 7.2.2 Asia-Pacific Mevalonolactone Sales in Value by Region (2026-2031) 61 8 Latin America Mevalonolactone by Country 62 8.1 Latin America Mevalonolactone Historic Market Size by Country 62 8.1.1 Latin America Mevalonolactone Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031 62 8.1.2 Latin America Mevalonolactone Sales in Volume by Country (2020-2025) 62 8.1.3 Latin America Mevalonolactone Sales in Value by Country (2020-2025) 63 8.2 Latin America Mevalonolactone Forecasted Market Size by Country 63 8.2.1 Latin America Mevalonolactone Sales in Volume by Country (2026-2031) 63 8.2.2 Latin America Mevalonolactone Sales in Value by Country (2026-2031) 64 9 Middle East and Africa Mevalonolactone by Country 65 9.1 Middle East and Africa Mevalonolactone Historic Market Size by Country 65 9.1.1 Middle East and Africa Mevalonolactone Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031 65 9.1.2 Middle East and Africa Mevalonolactone Sales in Volume by Country (2020-2025) 65 9.1.3 Middle East and Africa Mevalonolactone Sales in Value by Country (2020-2025) 66 9.2 Middle East and Africa Mevalonolactone Forecasted Market Size by Country 67 9.2.1 Middle East and Africa Mevalonolactone Sales in Volume by Country (2026-2031) 67 9.2.2 Middle East and Africa Mevalonolactone Sales in Value by Country (2026-2031) 67 10 Company Profiles 69 10.1 Adeka 69 10.1.1 Adeka Company Information 69 10.1.2 Adeka Introduction and Business Overview 69 10.1.3 Adeka Mevalonolactone Sales, Revenue and Gross Margin (2020-2025) 70 10.1.4 Adeka Mevalonolactone Products Offered 70 10.1.5 Adeka Recent Development 72 10.2 Hubei Guangao Biotechnology 72 10.2.1 Hubei Guangao Biotechnology Company Information 72 10.2.2 Hubei Guangao Biotechnology Introduction and Business Overview 73 10.2.3 Hubei Guangao Biotechnology Mevalonolactone Sales, Revenue and Gross Margin (2020-2025) 73 10.2.4 Hubei Guangao Biotechnology Mevalonolactone Products Offered 74 10.3 Hubei Wande Chemical 74 10.3.1 Hubei Wande Chemical Company Information 74 10.3.2 Hubei Wande Chemical Introduction and Business Overview 75 10.3.3 Hubei Wande Chemical Mevalonolactone Sales, Revenue and Gross Margin (2020-2025) 75 10.3.4 Hubei Wande Chemical Mevalonolactone Products Offered 75 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 76 11.1 Mevalonolactone Key Raw Materials 76 11.1.1 Key Raw Materials 76 11.1.2 Raw Materials Key Suppliers 77 11.2 Manufacturing Cost Structure 77 11.2.1 Raw Materials 78 11.2.2 Labor Cost 78 11.2.3 Manufacturing Expenses 78 11.3 Mevalonolactone Industrial Chain Analysis 78 11.4 Mevalonolactone Market Dynamics 79 11.4.1 Mevalonolactone Industry Trends 79 11.4.2 Mevalonolactone Market Drivers 80 11.4.3 Mevalonolactone Market Challenges 81 11.4.4 Mevalonolactone Market Restraints 81 12 Marketing Strategy Analysis, Distributors 82 12.1 Sales Channel 82 12.2 Mevalonolactone Distributors 82 12.3 Mevalonolactone Downstream Customers 83 13 Research Findings and Conclusion 84 14 Appendix 86 14.1 Research Methodology 86 14.1.1 Methodology/Research Approach 86 14.1.2 Data Source 89 14.2 Author Details 92 14.3 Disclaimer 93